Julia Sauerbeck

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Dual-Phase β-Amyloid PET Captures Neuronal Injury and Amyloidosis in Corticobasal Syndrome.

Dual-Phase β-Amyloid PET Captures Neuronal Injury and Amyloidosis in Corticobasal Syndrome.

Journal: Frontiers in aging neuroscience

Published: January 30, 2021

Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy.

Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy.

Journal: JAMA neurology

Published: November 09, 2020

Detection Gap of Right-Asymmetric Neuronal Degeneration by CERAD Test Battery in Alzheimer's Disease.

Detection Gap of Right-Asymmetric Neuronal Degeneration by CERAD Test Battery in Alzheimer's Disease.

Journal: Frontiers in aging neuroscience

Published: September 29, 2020

Cognitive reserve hypothesis in frontotemporal dementia: A FDG-PET study.

Cognitive reserve hypothesis in frontotemporal dementia: A FDG-PET study.

Journal: NeuroImage. Clinical

Published: August 27, 2020

In Vivo Assessment of Neuroinflammation in 4-Repeat Tauopathies.

In Vivo Assessment of Neuroinflammation in 4-Repeat Tauopathies.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: August 24, 2020

Regional gray matter-dedicated SUVR with 3D-MRI detects positive amyloid deposits in equivocal amyloid PET images.

Regional gray matter-dedicated SUVR with 3D-MRI detects positive amyloid deposits in equivocal amyloid PET images.

Journal: Annals of nuclear medicine

Published: July 12, 2020

Asymmetry of Fibrillar Plaque Burden in Amyloid Mouse Models.

Asymmetry of Fibrillar Plaque Burden in Amyloid Mouse Models.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: January 30, 2020

Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer's Disease with a Multi-Analytical Evaluation of Amyloid-β Positron Emission Tomography.

Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer's Disease with a Multi-Analytical Evaluation of Amyloid-β Positron Emission Tomography.

Journal: Journal of Alzheimer's disease : JAD

Published: January 28, 2020

Early-phase [18F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury.

Early-phase [18F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury.

Journal: European journal of nuclear medicine and molecular imaging

Published: January 02, 2020

PET Imaging of Astrogliosis and Tau Facilitates Diagnosis of Parkinsonian Syndromes.

PET Imaging of Astrogliosis and Tau Facilitates Diagnosis of Parkinsonian Syndromes.

Journal: Frontiers in aging neuroscience

Published: May 30, 2019

Update on endocrine hypertension

Update on endocrine hypertension

Journal: Der Internist

Published: October 04, 2018

Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms.

Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms.

Journal: Journal of Alzheimer's disease : JAD

Published: July 17, 2018

Showing 1-12 of 17

Last Updated: 09/26/2026